Khalifa M A, Montgomery E A, Azumi N, Gomes M N, Zeman R K, Min K W, Lack E E
Department of Pathology, Georgetown University Medical Center, Washington, DC, USA.
South Med J. 1997 Aug;90(8):793-9. doi: 10.1097/00007611-199708000-00005.
Solitary fibrous tumor (SFT) is a rare neoplasm that, in addition to its classic presentation as a pleural-based mass, can also be encountered in unusual sites. The main difficulty in making the diagnosis of SFTs results from the unfamiliarity with its diverse clinical and pathologic features. This series of SFTs, some with unusual clinicopathologic presentation, included nine women and two men, ranging in age from 28 years to 74 years (five in pleura, one in lung parenchyma, one in breast, and four in mediastinum). The tumors were locally excised in eight cases and were resected along with portions of lung parenchyma in three. A panel of immunohistochemical stains was used to characterize these tumors. They were all vimentin-positive and, with the exception of one case, CD34-positive. Tumors were negative with antibodies directed against cytokeratin, factor VIII-related antigen, S-100 protein, muscle-specific actin, and smooth-muscle actin. Various diagnoses were initially rendered for these clinically and pathologically diverse lesions by the examining pathologists. Awareness of the various gross and microscopic patterns of these tumors, the possibility of occurring in unusual sites, and the use of immunohistochemical stains, particularly CD34, should eliminate most of the difficulties in arriving at a correct diagnosis. One patient died of metastatic breast cancer; all other patients were alive and well with a median follow-up of 17 months.
孤立性纤维瘤(SFT)是一种罕见的肿瘤,除了典型地表现为胸膜肿块外,也可出现在不寻常的部位。诊断SFT的主要困难在于对其多样的临床和病理特征不熟悉。这组SFT,有些具有不寻常的临床病理表现,包括9名女性和2名男性,年龄从28岁至74岁(5例位于胸膜,1例位于肺实质,1例位于乳腺,4例位于纵隔)。8例肿瘤行局部切除,3例连同部分肺实质一并切除。采用一组免疫组织化学染色来对这些肿瘤进行特征性分析。它们均波形蛋白阳性,除1例例外,CD34阳性。肿瘤对细胞角蛋白、因子VIII相关抗原、S-100蛋白、肌肉特异性肌动蛋白和平滑肌肌动蛋白抗体呈阴性。检查的病理学家最初对这些临床和病理表现多样的病变做出了各种诊断。认识到这些肿瘤的各种大体和显微镜下形态、出现在不寻常部位的可能性以及免疫组织化学染色的应用,特别是CD34,应能消除做出正确诊断的大多数困难。1例患者死于转移性乳腺癌;所有其他患者均存活且情况良好,中位随访时间为17个月。